Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT06740825
Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects
32 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
RECRUITING
NCT06718179
Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents
3,150 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome
RECRUITING
NCT06691191
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
48 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
RECRUITING
NCT06324396
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
15 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Fontan Circulation
RECRUITING
NCT06220864
SNV1521 in Participants with Advanced Solid Tumors
200 Enrollment(s)
9 Study location(s)
INTERVENTIONAL (PHASE1)
Advanced Solid Tumor
RECRUITING
NCT05869591
DOAC in Patients with Child a or B Liver Cirrhosis
40 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Liver Cirrhosis
RECRUITING
NCT05480384
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab for Patients Who Are Disease Free After Completion of Trimodality Treatment for HER-2+ Cancers of Esophagus & Gastroesophageal Junction
25 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (PHASE2)
Esophageal Adenocarcinoma


Esophageal Cancer


HER-2 Protein Overexpression


Gastroesophageal-junction Cancer